Abstract
Purpose. The mechanism for the biliary excretion of 17β-estradiol17β0-d-glucuronide (E217βG), a cholestatic metabolite of estradiol, isstill controversial. The purpose of the present study is to examine thetransport of E217βG across the bile canalicular membrane.
Methods. We examined the uptake of [3H]E217βG by isolatedcanalicular membrane vesicles (CMVs) prepared from Sprague-Dawley (SD)rats and Eisai Hyperbilirubinemic rats (EHBR) whose canalicularmultispecific organic anion transporter/multidrug resistance associatedprotein 2 (cMOAT/MRP2) function is hereditarily defective. Also,in vivo biliary excretion of intravenously administered [3H]E217βGwas examined.
Results. In CMVs prepared from SD rats, but not from EHBR, amarked ATP-dependent uptake of [3H]E217βG was observed.Moreover, E217βG competitively inhibited the ATP-dependent uptake of[3H]2,4-dinitrophenyl-S-glutathione (DNP-SG). In addition, nosignificant inhibitory effect of verapamil (100 μM) and PSC-833 (5 μM) onthe uptake of [3H]E217βG was observed. In vivo, the biliary excretionof intravenously administered [3H]E217βG was severely impaired inEHBR while the biliary excretion of [3H]E217βG in SD rats wasreduced by administering a cholestatic dose (10 μmol/kg) unlabeledE217βG, but not by PSC-833 (3 mg/kg).
Conclusions. The transport of E217βG across the bile canalicularmembrane is predominantly mediated by cMOAT/MRP2.
Similar content being viewed by others
REFERENCES
M. Vore, Y. Liu, and L. Huang. Cholestatic properties and hepatic transport of steroid glucuronides. Drug. Metab. Rev. 29:183–203 (1997).
R. Bossard, B. Stieger, B. O'Neill, G. Fricker, and P. J. Meier. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J. Clin. Invest. 91:2714–2720 (1993).
M. Trauner, M. Arrese, C. J. Soroka, M. Ananthanarayanan, T. A. Koeppel, S. F. Schlosser, F. J. Suchy, D. Keppler, and J. L. Boyer. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroenterol. 113:255–264 (1997).
N. R. Koopen, H. Wolters, R. Havinga, R. J. Vonk, P. L. M. Jansen, and M. Müller. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not main cause of ethinylestradiol-induced cholestasis in the rat. Hepatol. 27:537–545 (1998).
B. Stieger and P. J. Meier. Bile acid and xenobiotic transporters in liver. Curr. Opin. Cell. Biol. 10:462–467 (1998).
H. Kouzuki, H. Suzuki, K. Ito, R. Ohashi, and Y. Sugiyama. Contribution of organic anion transporting polypeptide to uptake of its possible-substrates into rat hepatocyte. J. Pharmacol. Exp. Ther. 288:627–634 (1999).
L. Li, T. K. Lee, P. J. Meier, and N. Ballatori. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem. 273:16184–16191 (1998).
R. P. Oude Elferink, D. K. Meijer, F. Kuipers, P. L. Jansen, A. K. Groen, and G. M. Groothuis. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim. Biophys. Acta. 1241:215–268 (1995).
D. Keppler and J. Konig. Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB. J. 11:509–516 (1997).
H. Kusuhara, H. Suzuki, and Y. Sugiyama. The role of P-glycoprotein and canalicular multispecific organic anion transporter (cMOAT) in the hepatobiliary excretion of drugs. J. Pharm. Sci. 87:1025–1040 (1998).
H. Suzuki and Y. Sugiyama. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin. Liv. Dis. 18:359–376 (1998).
H. Takikawa, R. Yamazaki, N. Sano, and M. Yamanaka. Biliary excretion of estradiol-17β-glucuronide in the rat. Hepatol. 23:607–613 (1996).
K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama. Molecular cloning of canalicular multispecific organic anion transporter defective in Eisai hyperbilirubinemic rats. Am. J. Physiol. 35:G16–G22 (1997).
M. Büchler, J. Konig, M. Brom, J. Kartenbeck, H Spring, T. Horie, and D Keppler. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem. 271:15091–15098 (1996).
D. Lautier, Y. Canitrot, R. G. Deeley, and S. P. Cole. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52:967–977 (1996).
D. W. Loe, R. G. Deeley, and S. P. Cole. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer. 32:945–57 (1996).
M. Vore, T. Hoffman, and M. Gosland. ATP-dependent transport of β-estradiol 17-(β-D-glucuronide) in rat canalicular membrane vesicles. Am. J. Physiol. 271:G791–798 (1996).
L. Huang, T. Hoffmann, and M. Vore. Adenosine triphosphate-dependent transport of estradiol-17β (b-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells. Hepatol. 28:1371–1377 (1998).
K. Kobayashi, Y. Sogame, H. Hara, and K. Hayashi. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J. Biol. Chem. 265:7737–7741 (1990).
K. Niinuma, O. Takenaka, T. Horie, K. Kobayashi, Y. Kato, H. Suzuki, and Y. Sugiyama. kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-Dinitrophenyl)-glutathione and 6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole glucuronide. J. Pharmacol. Exp. Ther. 282:866–872 (1997).
M. Böhme, M. Büchler, M. Müller, and D. Keppler. Differential inhibition by cyclosporins of primary active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS. Lett. 333:193–196 (1993).
Y. Kamimoto, Z. Gatmaitan, J. Hsu, and I. M. Arias. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem. 264:11693–11698 (1989).
T. Yamada, Y. Kato, H. Kusuhara, M. Lemaire, and Y. Sugiyama Characterization of the transport of a cationic octapeptide, octreotide, in rat bile canalicular membrane: possible involvement of P-glycoprotein. Biol. Pharm. Bull. 21:874–878 (1998).
S. Song, H. Suzuki, R. Kawai, and Y. Sugiyama. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug. Metab. Dispos. 27:689–94 (1999).
T. Hirohashi, H. Suzuki, K. Ito, K. Kume, T. Shimizu, and Y. Sugiyama. Hepatic expression of multidrug resistance-associated protein (MRP)-like proteins maintained in Eisai hyper-bilirubinemic rats (EHBR). Mol. Pharmacol. 53:1068–1075 (1998).
T. Hirohashi, H. Suzuki, and Y. Sugiyama. Characterization of the transport properties of cloned rat multidrug resistance associated protein 3 (MRP3). J. Biol. Chem. 274:15181–15185 (1999).
J. Konig, D. Rost, Y. Cui, and D. Keppler. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatol. 29:1156–1163 (1999).
M. Kool, M. van der Linden, M. de Haas, G. L. Scheffer, J. M. L. de Vree, A. J. Smith, G. Jansen, G. J. Peters, N. Ponne, R. J. Scheper, R. P. J. Oude Elferink, F. Baas, and P. Borst. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. 96:6914–6919 (1999).
B. Stieger, K. Fattinger, J. Madon, G. A. Kullak-Ublick, and P. J. Meier. Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular Bile salt export pump (Bsep) of rat liver. Gastroenterol. 118:422–430 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morikawa, A., Goto, Y., Suzuki, H. et al. Biliary Excretion of 17β-Estradiol 17β-d-Glucuronide Is Predominantly Mediated by cMOAT/MRP2. Pharm Res 17, 546–552 (2000). https://doi.org/10.1023/A:1026412915168
Issue Date:
DOI: https://doi.org/10.1023/A:1026412915168